Edition:
India

Elanix Biotechnologies AG (ELNk.F)

ELNk.F on Frankfurt Stock Exchange

2.33EUR
23 May 2019
Change (% chg)

€-0.02 (-0.85%)
Prev Close
€2.35
Open
€2.33
Day's High
€2.33
Day's Low
€2.33
Volume
380
Avg. Vol
50,426
52-wk High
€3.26
52-wk Low
€1.00

Latest Key Developments (Source: Significant Developments)

Elanix Biotechnologies: Anja Silling To Become Chairman Of Supervisory Board
Thursday, 18 Apr 2019 

April 18 (Reuters) - Elanix Biotechnologies AG ::DGAP-ADHOC: ELANIX BIOTECHNOLOGIES AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD..SUPERVISORY BOARD OF ELANIX HAS NOMINATED ANJA SILLING TO BECOME CHAIRMAN OF BOARD.  Full Article

Elanix Biotechnologies: Chairman Of Supervisory Board Juergen Kullmann Resigns
Thursday, 14 Feb 2019 

Feb 14 (Reuters) - ELANIX BIOTECHNOLOGIES AG ::RESIGNATION IN SUPERVISORY BOARD.CHAIRMAN OF SUPERVISORY BOARD JUERGEN KULLMANN NOTIFIED THAT HE WILL RESIGN FROM OFFICE WITH IMMEDIATE EFFECT.KULLMANN RESIGNS DUE TO HEALTH REASONS.  Full Article

Elanix Biotechnologies Appoints Lee Ann Laurent-Applegate As Interim CEO
Monday, 12 Nov 2018 

Nov 12 (Reuters) - Elanix Biotechnologies AG ::LEE ANN LAURENT-APPLEGATE APPOINTED TO THE BOARD AS INTERIM CEO.  Full Article

Elanix Biotechnologies Revokes Appointment Of Tomas J. Svoboda As CEO With Immediate Effect
Monday, 12 Nov 2018 

Nov 12 (Reuters) - ELANIX BIOTECHNOLOGIES AG ::REVOKES APPOINTMENT OF TOMAS J. SVOBODA AS MEMBER OF EXECUTIVE BOARD AND AS CEO WITH IMMEDIATE EFFECT.LEE ANN LAURENT-APPLEGATE WAS APPOINTED TO THE BOARD INTERIM.  Full Article

Elanix Biotechnologies Places 301,763 Shares Of Current Cash Capital Increase
Monday, 1 Oct 2018 

Oct 1 (Reuters) - Elanix Biotechnologies AG ::HAS PLACED 301,763 SHARES OF THE CURRENT CASH CAPITAL INCREASE AND IS NEGOTIATING FURTHER FINANCING OPPORTUNITIES.SUBSCRIPTION PRICE OF EUR 2.75.GROSS PROCEEDS OF EUR 829,848.SHARE CAPITAL OF ELANIX WILL INCREASE TO A TOTAL OF 8,080,902 SHARES.  Full Article

Elanix Biotechnologies Resolves Cash Capital Increase Of Up To 10%
Tuesday, 24 Jul 2018 

July 24 (Reuters) - Elanix Biotechnologies AG ::ELANIX BIOTECHNOLOGIES - RESOLVES A CASH CAPITAL INCREASE WITH INDIRECT SUBSCRIPTION RIGHTS OF UP TO 10%, CORRESPONDING TO APPROX EUR 2.1 MILLION.TO INCREASE SHARE CAPITAL BY UP TO EUR 777,910.00 TO UP TO EUR 8,557,049.00.SUBSCRIPTION PERIOD RUNS FOR TWO WEEKS, EXPECTED FROM JULY 27, 2018 TO AUGUST 10, 201.SUBSCRIPTION PERIOD RUNS FOR TWO WEEKS, EXPECTED FROM JULY 27, 2018 TO AUGUST 10, 2018.SUBSCRIPTION PRICE SET AT EUR 2.75 PER SHARE.  Full Article

Elanix Biotechnologies Places All 679,920 Shares Of Current Cash Capital Increase
Monday, 11 Jun 2018 

June 11 (Reuters) - Elanix Biotechnologies AG ::DGAP-NEWS: ELANIX BIOTECHNOLOGIES AG: ELANIX BIOTECHNOLOGIES AG HAS PLACED ALL 679,920 SHARES OF THE CURRENT CASH CAPITAL INCREASE.GROSS PROCEEDS OF EUR 870,298.SHARE CAPITAL OF ELANIX WILL INCREASE TO A TOTAL OF 7,779,139 SHARES.  Full Article

Elanix Biotechnologies Appoints Egon Minar As COO/CFO
Tuesday, 29 May 2018 

May 29 (Reuters) - Elanix Biotechnologies AG ::DGAP-NEWS: ELANIX BIOTECHNOLOGIES AG: ELANIX BIOTECHNOLOGIES AG STRENGTHENS EXECUTIVE TEAM WITH APPOINTMENT OF EGON MINAR AS CHIEF OPERATING OFFICER / CHIEF FINANCIAL OFFICER.  Full Article

Elanix Biotechnologies Continues Private Placement At Subscription Price Of EUR 4.20
Tuesday, 12 Dec 2017 

Dec 12 (Reuters) - Elanix Biotechnologies AG ::DGAP-NEWS: ELANIX BIOTECHNOLOGIES AG ANNOUNCES CONTINUATION OF PRIVATE PLACEMENT AT SUBSCRIPTION PRICE OF EUR 4.20.  Full Article

Elanix Biotechnologies Signs Agreement With Dermacon
Friday, 1 Dec 2017 

Dec 1 (Reuters) - ELANIX BIOTECHNOLOGIES AG ::SIGNS AGREEMENT WITH DERMACON TO DEVELOP PROGENITOR CELL MEDICAL DEVICES TO ACCELERATE WOUND HEALING.  Full Article